S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.36 (+0.58%)
AAPL   173.71 (+1.46%)
MSFT   318.32 (+0.81%)
META   305.07 (+1.62%)
GOOGL   133.52 (+2.03%)
AMZN   128.98 (+1.46%)
TSLA   249.27 (-0.38%)
NVDA   448.11 (+3.02%)
NIO   8.79 (-2.77%)
BABA   86.29 (-0.52%)
AMD   102.23 (-0.57%)
T   14.86 (-1.07%)
F   12.33 (-0.72%)
MU   67.71 (-0.47%)
CGC   0.77 (-1.05%)
GE   109.60 (-0.86%)
DIS   80.93 (-0.15%)
AMC   7.93 (-0.75%)
PFE   33.19 (+0.06%)
PYPL   58.79 (+0.56%)
NFLX   380.68 (+0.82%)
S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.36 (+0.58%)
AAPL   173.71 (+1.46%)
MSFT   318.32 (+0.81%)
META   305.07 (+1.62%)
GOOGL   133.52 (+2.03%)
AMZN   128.98 (+1.46%)
TSLA   249.27 (-0.38%)
NVDA   448.11 (+3.02%)
NIO   8.79 (-2.77%)
BABA   86.29 (-0.52%)
AMD   102.23 (-0.57%)
T   14.86 (-1.07%)
F   12.33 (-0.72%)
MU   67.71 (-0.47%)
CGC   0.77 (-1.05%)
GE   109.60 (-0.86%)
DIS   80.93 (-0.15%)
AMC   7.93 (-0.75%)
PFE   33.19 (+0.06%)
PYPL   58.79 (+0.56%)
NFLX   380.68 (+0.82%)
S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.36 (+0.58%)
AAPL   173.71 (+1.46%)
MSFT   318.32 (+0.81%)
META   305.07 (+1.62%)
GOOGL   133.52 (+2.03%)
AMZN   128.98 (+1.46%)
TSLA   249.27 (-0.38%)
NVDA   448.11 (+3.02%)
NIO   8.79 (-2.77%)
BABA   86.29 (-0.52%)
AMD   102.23 (-0.57%)
T   14.86 (-1.07%)
F   12.33 (-0.72%)
MU   67.71 (-0.47%)
CGC   0.77 (-1.05%)
GE   109.60 (-0.86%)
DIS   80.93 (-0.15%)
AMC   7.93 (-0.75%)
PFE   33.19 (+0.06%)
PYPL   58.79 (+0.56%)
NFLX   380.68 (+0.82%)
S&P 500   4,279.05 (-0.21%)
DOW   33,357.21 (-0.45%)
QQQ   360.36 (+0.58%)
AAPL   173.71 (+1.46%)
MSFT   318.32 (+0.81%)
META   305.07 (+1.62%)
GOOGL   133.52 (+2.03%)
AMZN   128.98 (+1.46%)
TSLA   249.27 (-0.38%)
NVDA   448.11 (+3.02%)
NIO   8.79 (-2.77%)
BABA   86.29 (-0.52%)
AMD   102.23 (-0.57%)
T   14.86 (-1.07%)
F   12.33 (-0.72%)
MU   67.71 (-0.47%)
CGC   0.77 (-1.05%)
GE   109.60 (-0.86%)
DIS   80.93 (-0.15%)
AMC   7.93 (-0.75%)
PFE   33.19 (+0.06%)
PYPL   58.79 (+0.56%)
NFLX   380.68 (+0.82%)
NYSE:MNK

Mallinckrodt (MNK) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.04
$0.09
50-Day Range
$0.14
$0.75
52-Week Range
$0.75
$6.42
Volume
1,924 shs
Average Volume
2.62 million shs
Market Capitalization
$1.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MNK stock logo

About Mallinckrodt (NYSE:MNK) Stock

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.


MNK Stock News Headlines

Firm Retention Summary: Mallinckrodt
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
How is This "Hidden Gem" Thriving in a Turbulent Market?
While Wall Street flounders and giants like Amazon & Microsoft lay off thousands... One overlooked company has been quietly achieving over 400% growth. How? By buying, building, and scaling a portfolio of promising brands in high-margin, recession-resistant verticals.
Mallinckrodt To Initiate Chapter 11 Bankruptcy Proceedings
See More Headlines
Receive MNK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mallinckrodt and its competitors with MarketBeat's FREE daily newsletter.

MNK Company Calendar

Last Earnings
8/09/2023
Today
10/02/2023
Next Earnings (Estimated)
12/18/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
2,700
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$47.48 per share

Miscellaneous

Free Float
13,131,000
Market Cap
$1.12 million
Optionable
Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mark C. Trudeau
    President, Chief Executive Officer & Director
  • Bryan M. Reasons
    Chief Financial Officer & Executive Vice President
  • Steven Joseph Romano
    Chief Scientific Officer & Executive VP
  • Babatunde Adekunle Otulana
    Chief Medical Officer & Senior Vice President
  • Michele Robertson
    Chief Compliance Officer & Senior Vice President













MNK Stock - Frequently Asked Questions

When is Mallinckrodt's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, December 18th 2023.
View our MNK earnings forecast
.

How were Mallinckrodt's earnings last quarter?

Mallinckrodt plc (NYSE:MNK) issued its earnings results on Wednesday, August, 9th. The company reported ($1.45) earnings per share for the quarter. The firm earned $475 million during the quarter. Mallinckrodt had a positive trailing twelve-month return on equity of 20.32% and a negative net margin of 82.59%.

What guidance has Mallinckrodt issued on next quarter's earnings?

Mallinckrodt issued an update on its FY 2023 earnings guidance on Thursday, August, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.70 billion-$1.82 billion.

What other stocks do shareholders of Mallinckrodt own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mallinckrodt investors own include Gilead Sciences (GILD), Micron Technology (MU), Bausch Health Companies (BHC), Endo International (ENDP), Teva Pharmaceutical Industries (TEVA), Gerdau (GGB), AT&T (T), Alibaba Group (BABA), Advanced Micro Devices (AMD).

What is Mallinckrodt's stock symbol?

Mallinckrodt trades on the New York Stock Exchange (NYSE) under the ticker symbol "MNK."

What is Mallinckrodt's stock price today?

One share of MNK stock can currently be purchased for approximately $0.09.

How much money does Mallinckrodt make?

Mallinckrodt (NYSE:MNK) has a market capitalization of $1.12 million.

How many employees does Mallinckrodt have?

The company employs 2,700 workers across the globe.

How can I contact Mallinckrodt?

Mallinckrodt's mailing address is COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH BLANCHARDSTOWN, DUBLIN 15 L2, D15. The official website for the company is www.mallinckrodt.com. The company can be reached via phone at (531) 696-0000 or via email at investor.relations@mnk.com.

This page (NYSE:MNK) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -